Founded in 1998 and headquartered in Hong Kong, SETHIC was built by Alsatian engineer Jean-Yves Bruxer around a breakthrough discovery by scientist Dr. Bejit Ideas: centenarians don't just carry unique microbiome strains — they produce a distinctive metabolite profile that modern science can learn to reproduce. The insight was simple but radical: it is not the strains that deliver health. It is what they produce.

With a metabolite-based production facility in Japan and a multi-application R&I center in China, SETHIC operates at the intersection of a century of Japanese fermentation tradition and cutting-edge biotechnology.

Every day, the exposome — UV, pollution, stress, lack of sleep — is responsible for 80% of how we age. It attacks the body's frontlines: skin, scalp, oral mucosa, intimate flora, gut. If the frontlines hold, the body holds. Our Super-Metabiotics are engineered to reinforce them.

Our advanced co-culture biomimetic fermentation platforms, backed by 50+ proprietary scientific studies, patents, and publications, introduce a new therapeutic approach targeting the microbiome with a minimum environmental footprint. What makes them unique: AI-powered network pharmacology maps our 1,000+ active metabolites to hundreds of biological targets — building a fully traceable Component → Target → Effect framework. Not a black box. Explainable science.

This produces ingredients that work, like nature, in synergy across multiple biological pathways — with a cumulative effect superior to any single molecule in high concentration.

Proven in Asia's most demanding markets with 1,000+ customers.

Longevity Starts at the Frontlines. — Pioneers of Super-Metabiotics

SETHIC

Org chart

Teams

Offices

SETHIC

Org chart

Teams

Offices

Related companies